North America minimally invasive gastrointestinal (GI) surgical systems market is expected to grow by 3.9% annually in the forecast period and reach $3,998.7 million by 2030, owing to the rising incidents of GI disorders, benefits offered by minimally invasive GI surgery, increasing R&D investments, and technological advancements in MIS and robotics-based surgeries. Highlighted with 28 tables and 55 figures, this 112-page report “North America Minimally Invasive Gastrointestinal (GI) S...
Europe minimally invasive gastrointestinal (GI) surgical systems market accounted for $1,140.9 million in 2020 and will grow by 7.4% annually over 2020-2030 owing to the rising incidents of GI disorders, benefits offered by minimally invasive GI surgery, increasing R&D investments, and technological advancements in MIS and robotics-based surgeries. Highlighted with 38 tables and 59 figures, this 120-page report “Europe Minimally Invasive Gastrointestinal (GI) Surgical Systems Market 20...
Asia Pacific minimally invasive gastrointestinal (GI) surgical systems market will grow by 9.7% annually with a total addressable market cap of $17.69 billion over 2021-2030 owing to the rising incidents of GI disorders, benefits offered by minimally invasive GI surgery, increasing R&D investments, and technological advancements in MIS and robotics-based surgeries. Highlighted with 35 tables and 58 figures, this 120-page report “Asia Pacific Minimally Invasive Gastrointestinal (GI) Sur...
Global minimally invasive neurosurgical systems market will reach $1,242.9 million by 2030, growing by 12.1% annually over 2020-2030 owing to the rising incidents of neuro-disorders, benefits offered by minimally invasive neurosurgery, increasing R&D investments, and technological advancements in MIS and robotics-based surgeries. Highlighted with 89 tables and 86 figures, this 179-page report “Global Minimally Invasive Neurosurgical (MIN) Systems Market 2020-2030 by Offering, Product T...
North America minimally invasive neurosurgical systems market is expected to grow by 12.2% annually in the forecast period and reach $499.8 million by 2030 owing to the rising incidents of neuro-disorders, benefits offered by minimally invasive neurosurgery, increasing R&D investments, and technological advancements in MIS and robotics-based surgeries. Highlighted with 30 tables and 50 figures, this 112-page report “North America Minimally Invasive Neurosurgical (MIN) Systems Market 20...
Europe minimally invasive neurosurgical systems market accounted for $113.4 million in 2020 and will grow by 11.0% annually over 2020-2030 owing to the rising incidents of neuro-disorders, benefits offered by minimally invasive neurosurgery, increasing R&D investments, and technological advancements in MIS and robotics-based surgeries. Highlighted with 40 tables and 54 figures, this 120-page report “Europe Minimally Invasive Neurosurgical (MIN) Systems Market 2020-2030 by Offering, Pro...
Asia Pacific minimally invasive neurosurgical systems market will grow by 13.2% annually with a total addressable market cap of $2,269.1 million over 2021-2030 owing to the rising incidents of neurological disorders, benefits offered by minimally invasive neurosurgery, increasing R&D investments, and technological advancements in MIS and robotics-based surgeries. Highlighted with 37 tables and 53 figures, this 120-page report “Asia Pacific Minimally Invasive Neurosurgical (MIN) Systems...
Global preventive vaccines market will reach $80.47 billion by 2026, growing by 11.26% annually over 2020-2026 owing to increasing healthcare expenditure, new development of the vaccines, and rising need for preventive vaccines especially new COVID-19 vaccines. Highlighted with 110 tables and 84 figures, this 207-page report “Global Preventive Vaccines Market 2020-2026 by Vaccine Type, Disease, Administration, Patient, and Region: COVID-19 Impact and Growth Opportunity” is based on a ...
North America preventive vaccines market is expected to grow by 10.42% annually in the forecast period and reach $30.02 billion by 2026 owing to increasing healthcare expenditure, new development of the vaccines, and rising need for preventive vaccines especially new COVID-19 vaccines. Highlighted with 51 tables and 48 figures, this 131-page report “North America Preventive Vaccines Market 2020-2026 by Vaccine Type, Disease, Administration, Patient, and Country: COVID-19 Impact and Grow...
Europe preventive vaccines market accounted for $10.64 billion in 2020 and will grow by 10.72% annually over 2020-2026 owing to the increasing healthcare expenditure, new development of the vaccines, and rising need for preventive vaccines especially new COVID-19 vaccines. Highlighted with 61 tables and 52 figures, this 140-page report “Europe Preventive Vaccines Market 2020-2026 by Vaccine Type, Disease, Administration, Patient, and Country: COVID-19 Impact and Growth Opportunity” is...
